Literature DB >> 15066735

Control of endemic MRSA-what is the evidence? A personal view.

C Marshall1, S Wesselingh, M McDonald, D Spelman.   

Abstract

Although there is extensive literature on the control of MRSA, when that concerning epidemics is excluded, only a limited amount remains regarding the control of endemic MRSA. Several guidelines have been recently published recommending stringent control measures, which are often suggested based on their success in controlling MRSA outbreaks in hospitals with few MRSA or in containing MRSA cases introduced into a hospital with no MRSA. In these settings, multiple measures are usually introduced with apparently successful results. However, results may not be generalizable to other settings and we do not know the minimum effective measures required for MRSA containment. This paper aims critically to review the literature to determine whether evidence exists for the value of the infection control measures that are widely recommended in the endemic setting. Much of this literature is based on observational studies, with few randomized, controlled trials having been conducted. More well-designed studies are required before many of the principles on which we build infection control programmes can be regarded as evidence based.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066735     DOI: 10.1016/j.jhin.2004.02.001

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  19 in total

1.  [Prevention of transmission of methicillin-resistant Staphylococcus aureus (MRSA) infection: standard precautions instead of isolation: a 6-year surveillance in a university hospital].

Authors:  I Kappstein; K van der Mühlen; D Meschzan; V Vatou; S Bieg-Habermann
Journal:  Chirurg       Date:  2009-01       Impact factor: 0.955

2.  Impact of the reinforcement of a methicillin-resistant Staphylococcus aureus control programme: a 3-year evaluation by several indicators in a French university hospital.

Authors:  Matthieu Eveillard; Evelyne Lancien; Arnaud deLassence; Catherine Branger; Guilène Barnaud; Jocelyne-Anne Benlolo; Marie-Laure Joly-Guillou
Journal:  Eur J Epidemiol       Date:  2006-08-17       Impact factor: 8.082

3.  [Positive screening for MRSA--clinical consequences?].

Authors:  M Neumaier; I Kappstein; M A Scherer
Journal:  Unfallchirurg       Date:  2006-06       Impact factor: 1.000

4.  [Current issues of methicillin-resistant Staphylococcus aureus: epidemiology, diagnostics, prevention, and therapy].

Authors:  I Kappstein
Journal:  Chirurg       Date:  2006-06       Impact factor: 0.955

5.  Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans.

Authors:  Nestor M Quezada Joaquin; Daniel J Diekema; Eli N Perencevich; George Bailey; Patricia L Winokur; Marin L Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

6.  [Methicillin-resistant Staphylococcus aureus (MRSA) infections. Epidemiology, diagnostics, therapy, and prevention].

Authors:  Peter Heeg; Klaus Schröppel
Journal:  Med Klin (Munich)       Date:  2009-06-15

7.  Throat and rectal swabs may have an important role in MRSA screening of critically ill patients.

Authors:  Rahul Batra; Alice C Eziefula; Duncan Wyncoll; Jonathan Edgeworth
Journal:  Intensive Care Med       Date:  2008-05-24       Impact factor: 17.440

8.  Methicillin-resistant Staphylococcus aureus in a general intensive care unit.

Authors:  D S Thompson
Journal:  J R Soc Med       Date:  2004-11       Impact factor: 18.000

9.  Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.

Authors:  Philip Van De Griend; Loreen A Herwaldt; Bret Alvis; Mary DeMartino; Kristopher Heilmann; Gary Doern; Patricia Winokur; Diana DeSalvo Vonstein; Daniel Diekema
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

10.  Impact of methicillin resistant Staphylococcus aureus contact isolation units on medical care.

Authors:  Vincent Masse; Louis Valiquette; Soraya Boukhoudmi; Francis Bonenfant; Yasmine Talab; Jean-Christophe Carvalho; Isabelle Alarie; Nathalie Carrier; Paul Farand
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.